Drugmakers lie about toxicity
LAWSUITS ACCUSE OXYCONTIN MAKERS OF DOUBLE-DIPPING IN HUMAN MISERY
By DAVID KLEMENT
Executive Director, Institute for Strategic Policy Solutions
The family that owns Purdue Pharma, the company that made billions from the highly addictive opioid drug OxyContin, sought to profit from marketing products to overcome overdoses and treat addictions caused by their drug, even as the company was paying millions in penalties for misrepresenting the addictive qualities of it.
That is the astounding assertion of lawsuits filed by the attorneys general of READ MORE
David Klement - A Pulitzer Prize-winning journalist with 45 years of editing and writing experience for major metro as well as small-city newspapers.